Infliximab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Infliximab and local guidelines before prescribing.

Anti-TNF biologic

Mechanism

Chimeric monoclonal antibody neutralising TNF-alpha.

Uses

Crohn disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriasis, sarcoidosis (selected).

Dosing

4 more dose entries from the chapters

Side effects

Infusion reactions, infections, headache; reactivated TB, demyelination, hepatotoxicity, lupus-like syndrome.

Interactions

Methotrexate or azathioprine reduce antibody formation; live vaccines contraindicated.

Contraindications and cautions

Sepsis, active TB, moderate to severe heart failure

Monitoring

TB screen, infection, drug levels

Pregnancy and breastfeeding

Limited data

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

TB, hepatitis B and varicella screening; drug and antibody levels in loss of response.

More from the textbook: uses, cautions and other points
Where it is discussed in the book